Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure-based design of Tet repressor to optimize a new inducer specificity.

Eva-Maria Henssler1, Oliver Scholz, Susanne Lochner

  • 1Lehrstuhl für Mikrobiologie, Institut für Mikrobiologie, Biochemie und Genetik, Friedrich-Alexander Universität Erlangen-Nürnberg, Staudtstrasse 5, 91058 Erlangen, Germany.

Biochemistry
|July 21, 2004
PubMed
Summary

Researchers engineered a TetR repressor mutant with high specificity for 4-de(dimethylamino)anhydrotetracycline (4-ddma-atc), a non-antibiotic tetracycline analogue. This engineered protein offers precise control for tetracycline-inducible systems.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Selectfluor-based Polonovski Rearrangement Leading to Novel Entities for Synthetic and Medicinal Applications.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026
Same author

Neurotensin receptor 2 agonism attenuates adverse cardiac remodeling in preclinical models.

Science translational medicine·2026
Same author

Toward a Random Background for Ligand Optimization.

bioRxiv : the preprint server for biology·2026
Same author

Large Library Docking for Polypharmacology.

Journal of medicinal chemistry·2026
Same author

The Role of Intrinsically Disordered Domains in Regulating G Protein-Coupled Receptor Signaling.

Journal of the American Chemical Society·2025
Same author

A Warm Welcome to MedChem: The Frontiers in Medicinal Chemistry 2025.

ChemMedChem·2025

Area of Science:

  • Molecular Biology
  • Protein Engineering
  • Biochemistry

Background:

  • The tetracycline (tc) inducible system relies on the TetR repressor protein.
  • Wild-type TetR has broad specificity, responding to various tc analogues.
  • Existing TetR mutants exhibit altered, but not always specific, induction profiles.

Purpose of the Study:

  • To engineer a TetR repressor mutant with high specificity for 4-de(dimethylamino)anhydrotetracycline (4-ddma-atc).
  • To create a tool for precise control in tetracycline-inducible gene expression systems.
  • To investigate the structural basis of TetR specificity for tc derivatives.

Main Methods:

  • Site-directed mutagenesis of the TetR repressor protein.
  • Randomization of residues at positions 82 and 138 in TetR.

Related Experiment Videos

  • Screening of TetR mutants for specific induction by 4-ddma-atc.
  • Characterization of binding affinities using binding constants.

    • Main Results:

    • A novel TetR mutant, TetR H64K S135L S138I, was constructed.
    • This mutant exhibits a 200-fold increased specificity for 4-ddma-atc compared to anhydrotetracycline (atc).
    • The engineered TetR shows reduced affinity for doxycycline (dox) and atc, while maintaining affinity for 4-ddma-atc.
    • Analysis suggests tc variants bind to slightly different positions within the TetR binding pocket.

    Conclusions:

    • The TetR H64K S135L S138I mutant provides highly specific induction by 4-ddma-atc.
    • This engineered repressor offers enhanced precision for tetracycline-inducible gene expression.
    • Structural insights into TetR-ligand interactions were gained, highlighting the role of specific residues in determining tc analogue binding.